709 related articles for article (PubMed ID: 16319571)
1. The expert consensus guideline series. Treatment of behavioral emergencies 2005.
Allen MH; Currier GW; Carpenter D; Ross RW; Docherty JP;
J Psychiatr Pract; 2005 Nov; 11 Suppl 1():5-108; quiz 110-2. PubMed ID: 16319571
[TBL] [Abstract][Full Text] [Related]
2. The Expert Consensus Guideline Series. Treatment of behavioral emergencies.
Allen MH; Currier GW; Hughes DH; Reyes-Harde M; Docherty JP;
Postgrad Med; 2001 May; (Spec No):1-88; quiz 89-90. PubMed ID: 11500996
[TBL] [Abstract][Full Text] [Related]
3. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
4. Treatment of behavioral emergencies: a summary of the expert consensus guidelines.
Allen MH; Currier GW; Hughes DH; Docherty JP; Carpenter D; Ross R
J Psychiatr Pract; 2003 Jan; 9(1):16-38. PubMed ID: 15985913
[TBL] [Abstract][Full Text] [Related]
5. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
6. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
7. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
Sachs GS; Printz DJ; Kahn DA; Carpenter D; Docherty JP
Postgrad Med; 2000 Apr; Spec No():1-104. PubMed ID: 10895797
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
9. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
[TBL] [Abstract][Full Text] [Related]
10. The Expert Consensus Guideline Series. Treatment of depression in women.
Altshuler LL; Cohen LS; Moline ML; Kahn DA; Carpenter D; Docherty JP;
Postgrad Med; 2001 Mar; (Spec No):1-107. PubMed ID: 11500997
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Treatment of depression in women: a summary of the expert consensus guidelines.
Altshuler LL; Cohen LS; Moline ML; Kahn DA; Carpenter D; Docherty JP; Ross RW
J Psychiatr Pract; 2001 May; 7(3):185-208. PubMed ID: 15990522
[TBL] [Abstract][Full Text] [Related]
13. Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Wilson MP; Minassian A; Bahramzi M; Campillo A; Vilke GM
J Emerg Med; 2014 Jun; 46(6):808-13. PubMed ID: 24656982
[TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
15. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I; Preval H; Southard R; Francis A
Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
[TBL] [Abstract][Full Text] [Related]
16. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.
Kahn DA; Sachs GS; Printz DJ; Carpenter D; Docherty JP; Ross R
J Psychiatr Pract; 2000 Jul; 6(4):197-211. PubMed ID: 15990485
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of acute agitation.
Battaglia J
Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
[TBL] [Abstract][Full Text] [Related]
18. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians.
Naber D; Lambert M
CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194
[TBL] [Abstract][Full Text] [Related]
19. Best clinical practice with ziprasidone IM: update after 2 years of experience.
Zimbroff DL; Allen MH; Battaglia J; Citrome L; Fishkind A; Francis A; Herr DL; Hughes D; Martel M; Preval H; Ross R
CNS Spectr; 2005 Sep; 10(9):1-15. PubMed ID: 16247923
[TBL] [Abstract][Full Text] [Related]
20. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
Mendelowitz AJ
Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]